SFS 2018:1587 Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor

SFS2018-1587.pdf

Källa Regeringskansliets rättsdatabaser m.fl.

<div><style type="text/css"> <!-- p {margin: 0; padding: 0;} .ft10{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft11{font-size:28px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft12{font-size:21px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft13{font-size:11px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft14{font-size:9px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft15{font-size:13px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft16{font-size:19px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft17{font-size:19px;font-family:IXDHQS+TimesNewRomanPS;color:#000000;} .ft18{font-size:19px;font-family:DVOYYC+TimesNewRomanPS;color:#000000;} .ft19{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft110{font-size:14px;font-family:QXIDWH+TimesNewRomanPSMT;color:#000000;} .ft111{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft112{font-size:14px;line-height:18px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft20{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft21{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft22{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft23{font-size:13px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft24{font-size:9px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft25{font-size:17px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft26{font-size:11px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft27{font-size:13px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft28{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft29{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft30{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft31{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft32{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft33{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft34{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft40{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft41{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft42{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft43{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft44{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft50{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft51{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft52{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft53{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft54{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft60{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft61{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft62{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft63{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft64{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft70{font-size:14px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft71{font-size:17px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} .ft72{font-size:16px;font-family:ABCDEE+TimesNewRomanPS;color:#000000;} .ft73{font-size:16px;font-family:TimesNewRoman,Bold;color:#000000;} .ft74{font-size:17px;line-height:20px;font-family:ABCDEE+TimesNewRomanPSMT;color:#000000;} --> </style> <div id="page1-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft10">1 </p> <p style="position:absolute;top:155px;left:98px;white-space:nowrap" class="ft11"><b>Svensk f�rfattningssamling </b></p> <p style="position:absolute;top:222px;left:98px;white-space:nowrap" class="ft12"><b>F�rordning </b></p> <p style="position:absolute;top:245px;left:98px;white-space:nowrap" class="ft12"><b>om �ndring i f�rordningen (1999:58) om f�rbud mot vissa </b></p> <p style="position:absolute;top:268px;left:98px;white-space:nowrap" class="ft12"><b>h�lsofarliga varor </b></p> <p style="position:absolute;top:307px;left:98px;white-space:nowrap" class="ft10">Utf�rdad den 4 oktober 2018 </p> <p style="position:absolute;top:348px;left:98px;white-space:nowrap" class="ft111">Regeringen f�reskriver1 att bilagan till f�rordningen (1999:58) om f�rbud <br/>mot vissa h�lsofarliga varor ska ha f�ljande lydelse. </p> <p style="position:absolute;top:410px;left:115px;white-space:nowrap" class="ft10">Denna f�rordning tr�der i kraft den 12 november 2018. </p> <p style="position:absolute;top:451px;left:98px;white-space:nowrap" class="ft10">P� regeringens v�gnar </p> <p style="position:absolute;top:492px;left:98px;white-space:nowrap" class="ft10">ANNIKA STRANDH�LL </p> <p style="position:absolute;top:512px;left:385px;white-space:nowrap" class="ft111">Kjell Rempler <br/>(Socialdepartementet) </p> <p style="position:absolute;top:1118px;left:98px;white-space:nowrap" class="ft14">1 Se Europaparlamentets och r�dets direktiv (EU) 2015/1535 av den 9 september 2015 om ett </p> <p style="position:absolute;top:1130px;left:98px;white-space:nowrap" class="ft15">informationsf�rfarande betr�ffande tekniska f�reskrifter och betr�ffande f�reskrifter f�r informa-</p> <p style="position:absolute;top:1142px;left:98px;white-space:nowrap" class="ft15">tionssamh�llets tj�nster. </p> <p style="position:absolute;top:224px;left:649px;white-space:nowrap" class="ft16"><b>SFS</b></p> <p style="position:absolute;top:221px;left:683px;white-space:nowrap" class="ft17"><b> 2018:1587 </b></p> <p style="position:absolute;top:247px;left:649px;white-space:nowrap" class="ft112">Publicerad <br/>den</p> <p style="position:absolute;top:263px;left:671px;white-space:nowrap" class="ft110"> 9 oktober 2018 </p> </div> <div id="page2-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft20"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft20"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft21">2 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft22"><b>SFS </b></p> <p style="position:absolute;top:51px;left:578px;white-space:nowrap" class="ft23"><i>Bilaga</i>2<i> </i></p> <p style="position:absolute;top:86px;left:98px;white-space:nowrap" class="ft25"><b>F�rteckning �ver varor som ska anses som h�lsofarliga varor enligt </b></p> <p style="position:absolute;top:105px;left:98px;white-space:nowrap" class="ft25"><b>lagen om f�rbud mot vissa h�lsofarliga varor </b></p> <p style="position:absolute;top:133px;left:115px;white-space:nowrap" class="ft29">N-metyl-1-(3,4-metylendioxifenyl)-2-butylamin (MBDB) <br/>1-(3,4-metylendioxifenyl)-2-butylamin (BDB) <br/>5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT) <br/>5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT) <br/>5-metoxi-alfametyltryptamin (5-MeO-AMT) <br/>2,5-dimetoxi-4-etylfenetylamin (2C-E) <br/>alfa-metyltryptamin (AMT) <br/>2,5-dimetoxi-4-klorfenetylamin (2C-C) <br/>2,5-dimetoxi-4-metylfenetylamin (2C-D) <br/>4-acetoxi-N,N-diisopropyltryptamin (4-AcO-DIPT) <br/>4-hydroxi-N,N-diisopropyltryptamin (4-HO-DIPT) <br/>gammabutyrolakton (GBL) <br/>1,4-butandiol (1,4-BD) <br/>4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT) <br/>4-hydroxi-N,N-metylisopropyltryptamin (4-HO-MIPT) <br/>4-acetoxi-N,N-dietyltryptamin (4-AcO-DET) <br/>4-hydroxi-N,N-dietyltryptamin (4-HO-DET) <br/>1-(3-trifluormetylfenyl)piperazin (TFMPP) <br/>2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4) <br/>[2,3-dihydro-5-metyl-3-(4-morfolinylmetyl)pyrrolo[1,2,3-de]-1,4-</p> <p style="position:absolute;top:542px;left:98px;white-space:nowrap" class="ft21">bensoxazin-6-yl]-1-naftalenylmetanon (WIN 55,212-2) </p> <p style="position:absolute;top:562px;left:115px;white-space:nowrap" class="ft21">5-(1,1-dimetylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclo-</p> <p style="position:absolute;top:583px;left:98px;white-space:nowrap" class="ft21">hexyl]fenol (CP 55,940) </p> <p style="position:absolute;top:603px;left:115px;white-space:nowrap" class="ft29">(2-metyl-1-pentylindol-3-yl)-(naftalen-1-yl)metanon (JWH-007) <br/>(2-metyl-1-propyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-015) <br/>(1-hexyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-019) <br/>2-metylnaftalen-1-yl-(butylindol-3-yl)metanon (JWH-073 metylderivat) <br/>4-metoxinaftalen-1-yl-(1-pentylindol-2-metyl-3-yl)metanon (JWH-098) <br/>1-hexyl-2-fenyl-4-(1-naftoyl)pyrrol (JWH-147) <br/>(4-metoxyfenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4) <br/>4-metylhexan-2-amin (DMAA) <br/>4-(2-aminopropyl)bensofuran (4-APB) <br/>5-(2-aminopropyl)bensofuran (5-APB) <br/>6-(2-aminopropyl)bensofuran (6-APB) <br/>1-(1-bensofuran-5-yl)-N-metylpropan-2-amin (5-MAPB) <br/>1-(5-fluoropentyl)-N-tricyklo[3.3.1.13,7]dek-1-yl-1H-indol-3-</p> <p style="position:absolute;top:869px;left:98px;white-space:nowrap" class="ft21">karboxamid (STS-135) </p> <p style="position:absolute;top:889px;left:115px;white-space:nowrap" class="ft21">1-pentyl-N-tricyklo[3.3.1.13,7]dek-1-yl-1H-indol-3-karboxamid (APICA </p> <p style="position:absolute;top:909px;left:98px;white-space:nowrap" class="ft21">[JWH-018 adamantyl karboxamid]) </p> <p style="position:absolute;top:930px;left:115px;white-space:nowrap" class="ft21">1-pentyl-N-tricyklo[3.3.1.13,7]dek-1-yl-1H-indazol-3-karboxamid </p> <p style="position:absolute;top:950px;left:98px;white-space:nowrap" class="ft21">(AKB48) </p> <p style="position:absolute;top:971px;left:115px;white-space:nowrap" class="ft29">(1-pentyl-1H-indol-3-yl)tricyklo[3.3.1.13,7]dek-1-yl-metanon (AB-001) <br/>1-[(5-kloropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (JWH-018 </p> <p style="position:absolute;top:1011px;left:98px;white-space:nowrap" class="ft21">N-[5-kloropentyl] derivat) </p> <p style="position:absolute;top:1056px;left:98px;white-space:nowrap" class="ft20"> </p> <p style="position:absolute;top:1070px;left:98px;white-space:nowrap" class="ft24">2 Senaste lydelse 2018:539. �ndringen inneb�r bl.a. att (1-pentyl-1H-indol-3-yl)(2,2,3,3-</p> <p style="position:absolute;top:1082px;left:98px;white-space:nowrap" class="ft27">tetrametylcyclopropyl)metanon (UR-144), 1-(5-fluoropentyl)-1H-indol-3-karboxylsyra 8-</p> <p style="position:absolute;top:1094px;left:98px;white-space:nowrap" class="ft27">kinolinester </p> <p style="position:absolute;top:1094px;left:180px;white-space:nowrap" class="ft27">(5F-PB22), </p> <p style="position:absolute;top:1094px;left:266px;white-space:nowrap" class="ft27">N-[1-(aminokarbonyl)-2-metylpropyl]-1-(cyclohexylmetyl)-1H-</p> <p style="position:absolute;top:1106px;left:98px;white-space:nowrap" class="ft27">indazol-3-karboxamid (AB-CHMINACA), N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-pentyl-</p> <p style="position:absolute;top:1118px;left:98px;white-space:nowrap" class="ft27">1H-indazol-3-karboxamid (AB-PINACA),metyl-2-(1-(5-fluoropentyl)-1H-indazol-3-karbox-</p> <p style="position:absolute;top:1130px;left:98px;white-space:nowrap" class="ft27">amido)-3,3-dimetylbutanoat (5F-MDMB-PINACA) och N-[1-(2-fenyletyl)piperidin-4-yl]-N-</p> <p style="position:absolute;top:1142px;left:98px;white-space:nowrap" class="ft27">(2-fluorofenyl)propanamid (2-fluoro-fentanyl) tas bort ur f�rteckningen. </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft28"><b>2018:1587</b></p> </div> <div id="page3-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft30"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft30"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft31">3 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft32"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft31">N-[1-(aminokarbonyl)-2-metylpropyl]-1-[(4-fluorofenyl)metyl]-1H-</p> <p style="position:absolute;top:72px;left:98px;white-space:nowrap" class="ft31">indazol-3-karboxamid (AB-FUBINACA) </p> <p style="position:absolute;top:92px;left:115px;white-space:nowrap" class="ft31">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-((4-fluorofenyl)metyl)-1H-</p> <p style="position:absolute;top:113px;left:98px;white-space:nowrap" class="ft31">indazol-3-karboxamid (ADB-FUBINACA) </p> <p style="position:absolute;top:133px;left:115px;white-space:nowrap" class="ft31">N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-</p> <p style="position:absolute;top:153px;left:98px;white-space:nowrap" class="ft31">karboxamid (5F-AB-PINACA) </p> <p style="position:absolute;top:174px;left:115px;white-space:nowrap" class="ft31">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indol-3-</p> <p style="position:absolute;top:194px;left:98px;white-space:nowrap" class="ft31">karboxamid (ADBICA) </p> <p style="position:absolute;top:215px;left:115px;white-space:nowrap" class="ft34">kinolin-8-yl-1-pentyl-1H-indol-3-karboxylat (PB-22) <br/>kinolin-8-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FUB-PB-22) <br/>naftalen-1-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FDU-PB-22) <br/>kinolin-8-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-PB-22 </p> <p style="position:absolute;top:296px;left:98px;white-space:nowrap" class="ft31">indazol) </p> <p style="position:absolute;top:317px;left:115px;white-space:nowrap" class="ft34">kinolin-8-yl-1-(cyklohexylmetyl)-1H-indol-3-karboxylat (BB-22) <br/>4-hydroxi-3,3,4-trimetyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on </p> <p style="position:absolute;top:358px;left:98px;white-space:nowrap" class="ft31">(4-HTMPIPO) </p> <p style="position:absolute;top:378px;left:115px;white-space:nowrap" class="ft31">(1-heptyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)metanon </p> <p style="position:absolute;top:398px;left:98px;white-space:nowrap" class="ft31">(UR-144-heptylderivat) </p> <p style="position:absolute;top:419px;left:115px;white-space:nowrap" class="ft34">N-bensyl-1-(5-fluoropentyl)-1H-indol-3-karboxamid (5F-SDB-006) <br/>N-bensyl-1-pentyl-1H-indol-3-karboxamid (SDB-006) <br/>N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-</p> <p style="position:absolute;top:480px;left:98px;white-space:nowrap" class="ft31">karboxamid (ADB-PINACA) </p> <p style="position:absolute;top:500px;left:115px;white-space:nowrap" class="ft34">N-(naftalen-1-yl)-1-pentyl-1H-indazol-3-karboxamid (MN-18) <br/>1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indol-3-karboxamid (5F-NNEI) <br/>N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-</p> <p style="position:absolute;top:562px;left:98px;white-space:nowrap" class="ft31">karboxamid (5F-AB-144) </p> <p style="position:absolute;top:582px;left:115px;white-space:nowrap" class="ft34">(1-(5-fluoropentyl)-1H-indazol-3-yl)(naftalen-1-yl)metanon (THJ-2201) <br/>[1-(5-fluoropentyl)-1H-benso[d]imidazol-2-yl](naftalen-1-yl)metanon </p> <p style="position:absolute;top:623px;left:98px;white-space:nowrap" class="ft31">(FUBIMINA) </p> <p style="position:absolute;top:643px;left:115px;white-space:nowrap" class="ft31">metyl-2-(1-(5-fluoropentyl)-1H-indazol-3-karboxamido)-3-metylbuta-</p> <p style="position:absolute;top:664px;left:98px;white-space:nowrap" class="ft31">noat (5F-AMB) </p> <p style="position:absolute;top:684px;left:115px;white-space:nowrap" class="ft31">1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indazol-3-karboxamid </p> <p style="position:absolute;top:705px;left:98px;white-space:nowrap" class="ft31">(5F-MN-18) </p> <p style="position:absolute;top:725px;left:115px;white-space:nowrap" class="ft31">1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-pyrrolo[3,2-c]pyridin-3-karbox-</p> <p style="position:absolute;top:745px;left:98px;white-space:nowrap" class="ft31">amid (5F-PCN) </p> <p style="position:absolute;top:766px;left:115px;white-space:nowrap" class="ft34">naftalen-1-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-SDB-005) <br/>N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-[(2-fluorofenyl)metyl]-1H-</p> <p style="position:absolute;top:807px;left:98px;white-space:nowrap" class="ft31">indazol-3-karboxamid (AB-FUBINACA 2-fluorobensyl isomer) </p> <p style="position:absolute;top:827px;left:115px;white-space:nowrap" class="ft31">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-</p> <p style="position:absolute;top:847px;left:98px;white-space:nowrap" class="ft31">indazol-3-karboxamid (ADB-CHMINACA) </p> <p style="position:absolute;top:868px;left:115px;white-space:nowrap" class="ft31">7-kloro-N-[1-[((2-((cyklopropylsulfonyl)amino)-etyl)amino)karbonyl]-</p> <p style="position:absolute;top:888px;left:98px;white-space:nowrap" class="ft34">2,2-dimetyl-propyl]-1-(4-fluorobensyl)-1H-indazol-3-karboxamid (ADSB-<br/>FUB-187) </p> <p style="position:absolute;top:929px;left:115px;white-space:nowrap" class="ft31">adamant-1-yl-(1-[(N-metylpiperidin-2-yl)metyl]-1H-indol-3-yl)metanon </p> <p style="position:absolute;top:950px;left:98px;white-space:nowrap" class="ft31">(AM-1248) </p> <p style="position:absolute;top:970px;left:115px;white-space:nowrap" class="ft31">N-(2-fenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-karboxamid </p> <p style="position:absolute;top:990px;left:98px;white-space:nowrap" class="ft31">(CUMYL-5F-PICA) </p> <p style="position:absolute;top:1011px;left:115px;white-space:nowrap" class="ft31">1-(5-fluoropentyl)-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid </p> <p style="position:absolute;top:1031px;left:98px;white-space:nowrap" class="ft31">(CUMYL-5F-PINACA, SGT-25) </p> <p style="position:absolute;top:1052px;left:115px;white-space:nowrap" class="ft31">1-butyl-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid (CUMYL-</p> <p style="position:absolute;top:1072px;left:98px;white-space:nowrap" class="ft31">BICA) </p> <p style="position:absolute;top:1092px;left:115px;white-space:nowrap" class="ft31">N-(2-fenylpropan-2-yl)-1-pentyl-1H-indol-3-karboxamid (CUMYL-</p> <p style="position:absolute;top:1113px;left:98px;white-space:nowrap" class="ft31">PICA) </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft33"><b>2018:1587</b></p> </div> <div id="page4-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft40"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft40"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft41">4 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft42"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft41">N-(2-fenylpropan-2-yl)-1-pentyl-1H-indazol-3-karboxamid (CUMYL-</p> <p style="position:absolute;top:72px;left:98px;white-space:nowrap" class="ft41">PINACA) </p> <p style="position:absolute;top:92px;left:115px;white-space:nowrap" class="ft41">N-(2-fenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)metyl)-1H-</p> <p style="position:absolute;top:113px;left:98px;white-space:nowrap" class="ft41">indazol-3-karboxamid (CUMYL-THPINACA) </p> <p style="position:absolute;top:133px;left:115px;white-space:nowrap" class="ft41">(1-(5-fluoropentyl)-1H-indazol-3-yl)(2,2,3,3-tetrametylcyklopropyl)meta-</p> <p style="position:absolute;top:153px;left:98px;white-space:nowrap" class="ft41">non (FAB-144) </p> <p style="position:absolute;top:174px;left:115px;white-space:nowrap" class="ft41">N-(adamant-1-yl)-1-(4-fluorobensyl)-1H-indazol-3-karboxamid (FUB-</p> <p style="position:absolute;top:194px;left:98px;white-space:nowrap" class="ft41">AKB48) </p> <p style="position:absolute;top:215px;left:115px;white-space:nowrap" class="ft41">metyl-2-(1-(4-fluorobensyl)-1H-indazol-3-karboxamido)-3-metyl-</p> <p style="position:absolute;top:235px;left:98px;white-space:nowrap" class="ft41">butanoat (FUB-AMB) </p> <p style="position:absolute;top:255px;left:115px;white-space:nowrap" class="ft41">metyl-2-([1-(5-fluoropentyl)-1H-indol-3-yl]karboxamido)-3-metyl-</p> <p style="position:absolute;top:276px;left:98px;white-space:nowrap" class="ft41">butanoat (I-AMB) </p> <p style="position:absolute;top:296px;left:115px;white-space:nowrap" class="ft44">(4-metylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)metanon (mepirapim) <br/>naftalen-1-yl-1-(5-fluoropentyl)-1H-indol-3-karboxylat (NM-2201) <br/>N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-</p> <p style="position:absolute;top:358px;left:98px;white-space:nowrap" class="ft41">karboxamid (PX-1) </p> <p style="position:absolute;top:378px;left:115px;white-space:nowrap" class="ft41">N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indazol-</p> <p style="position:absolute;top:398px;left:98px;white-space:nowrap" class="ft41">3-karboxamid (PX-2) </p> <p style="position:absolute;top:419px;left:115px;white-space:nowrap" class="ft44">naftalen-1-yl-(1-pentyl-1H-indazol-3-yl)metanon (THJ-018) <br/>1-(3,4-metylendioxifenyl)-2-(pyrrolidin-1-yl)butan-1-on (MDPBP) <br/>2-(pyrrolidin-1-yl)-1-(tiofen-2-yl)butan-1-on (alfa-PBT) <br/>2-(pyrrolidin-1-yl)-1-(tiofen-2-yl)pentan-1-on (alfa-PVT) <br/>1-(4-metylfenyl)-2-(pyrrolidin-1-yl)hexan-1-on (MPHP) <br/>1-(4-klorofenyl)-2-(pyrrolidin-1-yl)propan-1-on (4Cl-alfa-PPP) <br/>1-fenyl-2-(pyrrolidin-1-yl)hexan-1-on (alfa-PHP) <br/>1-fenyl-2-(pyrrolidin-1-yl)heptan-1-on (alfa-PEP) <br/>1-(2,3-dihydro-1-bensofuran-5-yl)propan-2-amin (5-APDB) <br/>1-(2,3-dihydro-1-bensofuran-6-yl)propan-2-amin (6-APDB) <br/>1-(1-bensofuran-6-yl)-N-metylpropan-2-amin (6-MAPB) <br/>2-(etylamino)-1-(4-metylfenyl)pentan-1-on (N-etyl-4-metylnorpente-</p> <p style="position:absolute;top:664px;left:98px;white-space:nowrap" class="ft41">dron) </p> <p style="position:absolute;top:684px;left:115px;white-space:nowrap" class="ft41">[1-[(tetrahydro-2H-pyran-4-yl)metyl]-1H-indol-3-yl](2,2,3,3-tetrametyl-</p> <p style="position:absolute;top:705px;left:98px;white-space:nowrap" class="ft41">cyklopropyl)metanon (A-834735) </p> <p style="position:absolute;top:725px;left:115px;white-space:nowrap" class="ft41">N-(adamantan-2-yl)-1-[(tetrahydro-2H-pyran-4-yl)metyl]-1H-indazol-3-</p> <p style="position:absolute;top:745px;left:98px;white-space:nowrap" class="ft41">karboxamid (adamantyl-THPINACA) </p> <p style="position:absolute;top:766px;left:115px;white-space:nowrap" class="ft41">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-</p> <p style="position:absolute;top:786px;left:98px;white-space:nowrap" class="ft41">indol-3-karboxamid (ADB-CHMICA) </p> <p style="position:absolute;top:807px;left:115px;white-space:nowrap" class="ft41">N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(4-fluorobensyl)-1H-indazol-</p> <p style="position:absolute;top:827px;left:98px;white-space:nowrap" class="ft41">3-karboxamid (APP-FUBINACA) </p> <p style="position:absolute;top:847px;left:115px;white-space:nowrap" class="ft44">naftalen-1-yl-(9-pentyl-9H-karbazol-3-yl)metanon (EG-018) <br/>(1-(4-fluorobensyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)meta-</p> <p style="position:absolute;top:888px;left:98px;white-space:nowrap" class="ft41">non (FUB-144) </p> <p style="position:absolute;top:909px;left:115px;white-space:nowrap" class="ft44">kinolin-8-yl-1-pentyl-1H-indazol-3-karboxylat (PB-22 indazol) <br/>N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H-indazol-3-</p> <p style="position:absolute;top:950px;left:98px;white-space:nowrap" class="ft41">karboxamid (AB-PINACA N-(2-fluoropentyl) isomer, 2F-AB-PINACA) </p> <p style="position:absolute;top:970px;left:115px;white-space:nowrap" class="ft41">N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(cyklohexylmetyl)-1H-</p> <p style="position:absolute;top:990px;left:98px;white-space:nowrap" class="ft41">indazol-3-karboxamid (APP-CHMINACA) </p> <p style="position:absolute;top:1011px;left:115px;white-space:nowrap" class="ft41">N-(adamantyl)-1-(5-kloropentyl)-1H-indazol-3-karboxamid </p> <p style="position:absolute;top:1031px;left:98px;white-space:nowrap" class="ft41">(5C-AKB48) </p> <p style="position:absolute;top:1052px;left:115px;white-space:nowrap" class="ft41">metyl-2-(1-(4-fluorobensyl)-1H-indol-3-karboxamido)-3,3-dimetylbuta-</p> <p style="position:absolute;top:1072px;left:98px;white-space:nowrap" class="ft41">noat (MDMB-FUBICA) </p> <p style="position:absolute;top:1092px;left:115px;white-space:nowrap" class="ft41">metyl-2-(1-(4-fluorobensyl)-1H-indazol-3-karboxamido)-3,3-dimetyl-</p> <p style="position:absolute;top:1113px;left:98px;white-space:nowrap" class="ft41">butanoat (MDMB-FUBINACA) </p> <p style="position:absolute;top:1133px;left:115px;white-space:nowrap" class="ft41">naftalen-1-yl-1-pentyl-1H-indazol-3-karboxylat (SDB-005) </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft43"><b>2018:1587</b></p> </div> <div id="page5-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft50"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft50"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft51">5 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft52"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft51">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-</p> <p style="position:absolute;top:72px;left:98px;white-space:nowrap" class="ft51">indazol-3-karboxamid (5F-ADB-PINACA) </p> <p style="position:absolute;top:92px;left:115px;white-space:nowrap" class="ft54">N-etyl-1,2-difenyletanamin (efenidin, NEDPA) <br/>N-(1,2-difenyletyl)propan-2-amin (NPDPA) <br/>N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-fluorofenyl)butanamid (4-fluoro-</p> <p style="position:absolute;top:153px;left:98px;white-space:nowrap" class="ft51">butyrfentanyl, 4F-BF) </p> <p style="position:absolute;top:174px;left:115px;white-space:nowrap" class="ft54">1-(4-klorofenyl)-2-(metylamino)propan-1-on (4-CMC, klefedron) <br/>1-(3-klorofenyl)-2-(metylamino)propan-1-on (3-CMC, klofedron) <br/>1-(4-bromofenyl)-2-(metylamino)propan-1-on (brefedron, 4-BMC) <br/>2-amino-1-(4-bromo-2,5-dimetoxifenyl)etanon (bk-2C-B) <br/>(1-(5-fluoropentyl)-1H-indazol-3-yl)(pyrrolidin-1-yl)metanon </p> <p style="position:absolute;top:276px;left:98px;white-space:nowrap" class="ft51">(5F-PY-PINACA) </p> <p style="position:absolute;top:296px;left:115px;white-space:nowrap" class="ft51">(1-(5-fluoropentyl)-1H-indol-3-yl)(pyrrolidin-1-yl)metanon </p> <p style="position:absolute;top:317px;left:98px;white-space:nowrap" class="ft51">(5F-PY-PICA) </p> <p style="position:absolute;top:337px;left:115px;white-space:nowrap" class="ft51">etyl-2-(1-[4-fluorobensyl]-1H-indazol-3-karboxamido)-3-metylbutanoat </p> <p style="position:absolute;top:358px;left:98px;white-space:nowrap" class="ft51">(EMB-FUBINACA) </p> <p style="position:absolute;top:378px;left:115px;white-space:nowrap" class="ft51">etyl-2-(1-[5-fluoropentyl]-1H-indazol-3-karboxamido)-3-metylbutanoat </p> <p style="position:absolute;top:398px;left:98px;white-space:nowrap" class="ft51">(5F-EMB-PINACA) </p> <p style="position:absolute;top:419px;left:115px;white-space:nowrap" class="ft51">metyl-2-(9-(cyklohexylmetyl)-9H-karbazol-3-karboxamido)-3,3-dime-</p> <p style="position:absolute;top:439px;left:98px;white-space:nowrap" class="ft51">tylbutanoat (MDMB-CHMCZCA) </p> <p style="position:absolute;top:460px;left:115px;white-space:nowrap" class="ft51">N,N-dietyl-6-metyl-1-propionyl-9,10-didehydroergolin-8-karboxamid </p> <p style="position:absolute;top:480px;left:98px;white-space:nowrap" class="ft51">(1p-LSD) </p> <p style="position:absolute;top:500px;left:115px;white-space:nowrap" class="ft51">2-[(metylamino)metyl]-3,4-dihydro-(2H)-naftalen-1-on (meftetramin, </p> <p style="position:absolute;top:521px;left:98px;white-space:nowrap" class="ft51">MTTA) </p> <p style="position:absolute;top:541px;left:115px;white-space:nowrap" class="ft51">1-(2,3-dihydrobensofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on </p> <p style="position:absolute;top:562px;left:98px;white-space:nowrap" class="ft51">(5-DBFPV) </p> <p style="position:absolute;top:582px;left:115px;white-space:nowrap" class="ft51">1-(3,4-dimetoxifenyl)-2-(pyrrolidin-1-yl)pentan-1-on (3,4-dimetoxi-alfa-</p> <p style="position:absolute;top:602px;left:98px;white-space:nowrap" class="ft51">PVP) </p> <p style="position:absolute;top:623px;left:115px;white-space:nowrap" class="ft51">1-(3,4-dimetoxifenyl)-2-(pyrrolidin-1-yl)hexan-1-on (3,4-dimetoxi-alfa-</p> <p style="position:absolute;top:643px;left:98px;white-space:nowrap" class="ft51">PHP) </p> <p style="position:absolute;top:664px;left:115px;white-space:nowrap" class="ft54">1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)heptan-1-on (4F-alfa-PEP) <br/>1-fenyl-2-(pyrrolidin-1-yl)oktan-1-on (alfa-POP) <br/>1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)propan-1-on (4-MeO-alfa-PPP) <br/>2-(etylamino)-1-(2-metylfenyl)propan-1-on (2-MEC) <br/>3-metoxi-2-(metylamino)-1-(4-metylfenyl)propan-1-on (mexedron, </p> <p style="position:absolute;top:766px;left:98px;white-space:nowrap" class="ft51">4-MMC-OMe) </p> <p style="position:absolute;top:786px;left:115px;white-space:nowrap" class="ft51">N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-metoxifenyl)butanamid </p> <p style="position:absolute;top:807px;left:98px;white-space:nowrap" class="ft51">(4-metoxibutyrfentanyl, 4-MeO-BF) </p> <p style="position:absolute;top:827px;left:115px;white-space:nowrap" class="ft54">1-(5-fluoropentyl)-N-fenyl-1H-indol-3-karboxamid (LTI-701) <br/>(naftalen-1-yl)[4-(pentyloxi)naftalen-1-yl]metanon (CRA-13) <br/>[9-(5-fluoropentyl)-9H-karbazol-3-yl](naftalen-1-yl)metanon (EG-2201) <br/>metyl-2-(1-(cyklohexylmetyl)-1H-indol-3-karboxamido)-3-metyl-</p> <p style="position:absolute;top:909px;left:98px;white-space:nowrap" class="ft51">butanoat (MMB-CHMICA, AMB-CHMICA) </p> <p style="position:absolute;top:929px;left:115px;white-space:nowrap" class="ft54">etyl-2-(naftalen-2-yl)-2-(piperidin-2-yl)acetat (etylnaftidat, HDEP-28) <br/>2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on </p> <p style="position:absolute;top:970px;left:98px;white-space:nowrap" class="ft51">(TH-PVP) </p> <p style="position:absolute;top:990px;left:115px;white-space:nowrap" class="ft54">1-(4-klorofenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4Cl-alfa-PVP) <br/>1-(4-bromofenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4Br-alfa-PVP) <br/>1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4-MeO-alfa-PVP) <br/>1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)butan-1-on (4F-alfa-PBP) <br/>1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)butan-1-on (4-MeO-alfa-PBP) <br/>1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)heptan-1-on (4-MeO-alfa-PEP) <br/>1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)hexan-1-on (4F-alfa-PHP) </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft53"><b>2018:1587</b></p> </div> <div id="page6-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft60"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft60"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft61">6 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft62"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft61">2-(metylamino)-1-(4-metylfenyl)butan-1-on (4-metylbufedron, </p> <p style="position:absolute;top:72px;left:98px;white-space:nowrap" class="ft61">4-Me-MABP) </p> <p style="position:absolute;top:92px;left:115px;white-space:nowrap" class="ft64">2-(metylamino)-1-(4-metylfenyl)pentan-1-on (4-metylpentedron) <br/>1-fenyl-2-[(1-metyletyl)amino]pentan-1-on (N-isopropylnorpentedron, </p> <p style="position:absolute;top:133px;left:98px;white-space:nowrap" class="ft61">NiPP) </p> <p style="position:absolute;top:153px;left:115px;white-space:nowrap" class="ft61">1-(4-fluorofenyl)-2-[(1-metyletyl)amino]pentan-1-on (4F-N-isopropyl-</p> <p style="position:absolute;top:174px;left:98px;white-space:nowrap" class="ft61">norpentedron) </p> <p style="position:absolute;top:194px;left:115px;white-space:nowrap" class="ft64">1-(4-fluorofenyl)-2-(metylamino)pentan-1-on (4F-pentedron) <br/>2-(etylamino)-1-fenylpentan-1-on (N-etylnorpentedron) <br/>2-(etylamino)-1-fenylhexan-1-on (N-etylnorhexedron) <br/>1-(1,3-bensodioxol-5-yl)-2-(etylamino)pentan-1-on (efylon) <br/>2-(etylamino)-1-(4-klorofenyl)propan-1-on (4-kloroetkatinon, 4-CEC) <br/>N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-klorofenyl)-2-metylpropanamid </p> <p style="position:absolute;top:317px;left:98px;white-space:nowrap" class="ft61">(4-kloroisobutyrfentanyl, 4Cl-iBF) </p> <p style="position:absolute;top:337px;left:115px;white-space:nowrap" class="ft64">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]pentanamid (valerylfentanyl) <br/>N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]cyklopentankarboxamid </p> <p style="position:absolute;top:378px;left:98px;white-space:nowrap" class="ft61">(cyklopentylfentanyl) </p> <p style="position:absolute;top:398px;left:115px;white-space:nowrap" class="ft64">1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)oktan-1-on (4-MeO-alfa-POP) <br/>1-(4-cyanobutyl)-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid </p> <p style="position:absolute;top:439px;left:98px;white-space:nowrap" class="ft61">(CUMYL-4CN-BINACA) </p> <p style="position:absolute;top:460px;left:115px;white-space:nowrap" class="ft61">2-(2-fluorofenyl)-2-(metylamino)cyklohexanon (2-fluorodeskloroketa-</p> <p style="position:absolute;top:480px;left:98px;white-space:nowrap" class="ft61">min) </p> <p style="position:absolute;top:500px;left:115px;white-space:nowrap" class="ft64">2-fenyl-2-(metylamino)cyklohexanon (deskloroketamin) <br/>etyl-2-(4-fluorofenyl)-2-(piperidin-2-yl)acetat (4-fluoroetylfenidat, </p> <p style="position:absolute;top:541px;left:98px;white-space:nowrap" class="ft61">4F-EPH) </p> <p style="position:absolute;top:562px;left:115px;white-space:nowrap" class="ft61">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-benso[d][1,3]dioxol-5-karbox-</p> <p style="position:absolute;top:582px;left:98px;white-space:nowrap" class="ft61">amid (bensodioxolfentanyl) </p> <p style="position:absolute;top:602px;left:115px;white-space:nowrap" class="ft64">N-[2-(dietylamino)cyklohexyl]-3,4-dikloro-N-metylbensamid (U-49900) <br/>1-fenyl-4-metyl-2-(pyrrolidin-1-yl)pentan-1-on (alfa-PiHP) <br/>1-fenyl-2-(1-metyletylamino)hexan-1-on (N-isopropylnorhexedron, </p> <p style="position:absolute;top:664px;left:98px;white-space:nowrap" class="ft61">NiPH) </p> <p style="position:absolute;top:684px;left:115px;white-space:nowrap" class="ft61">2-(etylamino)-1-(4-fluorofenyl)butan-1-on (4-fluoro-N-etylbufedron, </p> <p style="position:absolute;top:705px;left:98px;white-space:nowrap" class="ft61">4F-NEB) </p> <p style="position:absolute;top:725px;left:115px;white-space:nowrap" class="ft61">N-(2-fenylpropan-2-yl)-1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridin-3-</p> <p style="position:absolute;top:745px;left:98px;white-space:nowrap" class="ft61">karboxamid (CUMYL-5F-P7AICA) </p> <p style="position:absolute;top:766px;left:115px;white-space:nowrap" class="ft61">(1-metoxi-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-</p> <p style="position:absolute;top:786px;left:98px;white-space:nowrap" class="ft61">indazol-3-karboxylat (MO-AMB, MO-CHMINACA) </p> <p style="position:absolute;top:807px;left:115px;white-space:nowrap" class="ft61">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-3-fenylpropanamid (3-fenyl-</p> <p style="position:absolute;top:827px;left:98px;white-space:nowrap" class="ft61">propanoylfentanyl) </p> <p style="position:absolute;top:847px;left:115px;white-space:nowrap" class="ft64">N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]bensamid (bensoylfentanyl) <br/>N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-2,2,3,3-tetrametylcyklo-</p> <p style="position:absolute;top:888px;left:98px;white-space:nowrap" class="ft61">propan-1-karboxamid (tetrametylcyklopropanfentanyl) </p> <p style="position:absolute;top:909px;left:115px;white-space:nowrap" class="ft61">2-(2,4-diklorofenyl)-N-[2-(dimetylamino)cyklohexyl]-N-metylacetamid </p> <p style="position:absolute;top:929px;left:98px;white-space:nowrap" class="ft61">(U-48800) </p> <p style="position:absolute;top:950px;left:115px;white-space:nowrap" class="ft64">4-acetoxi-N-etyl-N-metyltryptamin (4-AcO-MET) <br/>1-(4-fluorofenyl)-4-metyl-2-(pyrrolidin-1-yl)pentan-1-on (4F-alfa-PiHP) <br/>2-(etylamino)-1-(4-fluorofenyl)pentan-1-on (4-fluoro-N-etylpentedron, </p> <p style="position:absolute;top:1011px;left:98px;white-space:nowrap" class="ft61">4F-NEP) </p> <p style="position:absolute;top:1031px;left:115px;white-space:nowrap" class="ft64">1-(1-bensofuran-6-yl)-N-etylpropan-2-amin (6-EAPB) <br/>N-(1-bensylpiperidin-4-yl)-N-fenylacetamid (acetylbensylfentanyl) <br/>N-(1-bensylpiperidin-4-yl)-N-fenylbensamid (bensoylbensylfentanyl) <br/>N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-kloropentyl)-1H-indazol-3-</p> <p style="position:absolute;top:1113px;left:98px;white-space:nowrap" class="ft61">karboxamid (5Cl-AB-PINACA) </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft63"><b>2018:1587</b></p> </div> <div id="page7-div" style="position:relative;width:892px;height:1262px;"> <img width="892" height="1262" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:0px;left:619px;white-space:nowrap" class="ft70"> </p> <p style="position:absolute;top:1212px;left:98px;white-space:nowrap" class="ft70"> </p> <p style="position:absolute;top:1129px;left:794px;white-space:nowrap" class="ft71">7 </p> <p style="position:absolute;top:52px;left:676px;white-space:nowrap" class="ft72"><b>SFS </b></p> <p style="position:absolute;top:51px;left:115px;white-space:nowrap" class="ft71">1-(4-cyanobutyl)-N-(2-fenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-</p> <p style="position:absolute;top:72px;left:98px;white-space:nowrap" class="ft71">karboxamid (CUMYL-4CN-B7AICA) </p> <p style="position:absolute;top:92px;left:115px;white-space:nowrap" class="ft74">4-hydroxi-N,N-dipropyltryptamin (4-HO-DPT) <br/>N-etyl-N-metyltryptamin (MET) <br/>3-[1-(etylamino)cyklohexyl]fenol (3-hydroxieticyklidin, 3-HO-PCE) <br/>N-etyl-1-(4-fluorofenyl)propan-2-amin (4-fluoroetamfetamin, 4-FEA) <br/>2-(etylamino)-1-fenyl-4-metylpentan-1-on (NEiH) <br/>1-(3-fluorofenyl)-2-(pyrrolidin-1-yl)pentan-1-on (3F-alfa-PVP) <br/>N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-hydroxifenyl)butanamid </p> <p style="position:absolute;top:235px;left:98px;white-space:nowrap" class="ft71">(4-hydroxibutyrfentanyl) </p> <p style="position:absolute;top:255px;left:115px;white-space:nowrap" class="ft71">N-[2-(dimetylamino)cyklohexyl]-N-isopropyl-3,4-diklorobensamid </p> <p style="position:absolute;top:276px;left:98px;white-space:nowrap" class="ft71">(isopropyl-U-47700) </p> <p style="position:absolute;top:296px;left:115px;white-space:nowrap" class="ft71">4-(2-fluorofenyl)-2-kloro-9-metyl-6H-tieno[3,2-f][1,2,4]triazolo[4,3-a] </p> <p style="position:absolute;top:317px;left:98px;white-space:nowrap" class="ft71">[1,4]diazepin (fluklotizolam) </p> <p style="position:absolute;top:337px;left:115px;white-space:nowrap" class="ft71">2-(dimetylamino)-1-(4-klorofenyl)propan-1-on (4-klorodimetylkatinon, </p> <p style="position:absolute;top:358px;left:98px;white-space:nowrap" class="ft71">4-CDMC, 4-CDC) </p> <p style="position:absolute;top:378px;left:115px;white-space:nowrap" class="ft71">2-(dimetylamino)-1-(4-metylfenyl)propan-1-on (4-metyl-N,N-dimetyl-</p> <p style="position:absolute;top:398px;left:98px;white-space:nowrap" class="ft71">katinon, 4-MDMC) </p> <p style="position:absolute;top:419px;left:115px;white-space:nowrap" class="ft74">1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)butan-1-on (5-PPDi) <br/>N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-3-(4-fluoro-</p> <p style="position:absolute;top:460px;left:98px;white-space:nowrap" class="ft71">fenyl)-1H-pyrazol-5-karboxamid (3,5-AB-CHMFUPPYCA) </p> <p style="position:absolute;top:480px;left:115px;white-space:nowrap" class="ft71">metyl-3,3-dimetyl-2-[1-(pent-4-en-1-yl)-1H-indazol-3-karboxamido]-</p> <p style="position:absolute;top:500px;left:98px;white-space:nowrap" class="ft71">butanoat (MDMB-4en-PINACA) </p> <p style="position:absolute;top:521px;left:115px;white-space:nowrap" class="ft71">metyl-3-metyl-2-[1-(pent-4-en-1-yl)-1H-indol-3-karboxamido]butanoat </p> <p style="position:absolute;top:541px;left:98px;white-space:nowrap" class="ft71">(MMB-022, AMB-4en-PICA) </p> <p style="position:absolute;top:562px;left:115px;white-space:nowrap" class="ft71">metyl-3-fenyl-2-[1-(5-fluoropentyl)-1H-indol-3-karboxamido]propanoat </p> <p style="position:absolute;top:582px;left:98px;white-space:nowrap" class="ft71">(MPhP-2201) </p> <p style="position:absolute;top:602px;left:115px;white-space:nowrap" class="ft71">N-[2-(dimetylamino)cyklohexyl]-N-metyl-2H-1,3-bensodioxol-</p> <p style="position:absolute;top:623px;left:98px;white-space:nowrap" class="ft71">5-karboxamid (3,4-metylendioxi-U-47700) </p> <p style="position:absolute;top:643px;left:115px;white-space:nowrap" class="ft74">salvinorin A <br/>alla delar av v�xten Salvia divinorum fr�n vilka salvinorin A inte blivit </p> <p style="position:absolute;top:684px;left:98px;white-space:nowrap" class="ft71">extraherat och oavsett under vilka ben�mningar de f�rekommer </p> <p style="position:absolute;top:705px;left:115px;white-space:nowrap" class="ft74"> <br/>Salter av �mnena n�r s�dana kan f�rekomma. </p> <p style="position:absolute;top:745px;left:98px;white-space:nowrap" class="ft71"> </p> <p style="position:absolute;top:49px;left:709px;white-space:nowrap" class="ft73"><b>2018:1587</b></p> </div> </div>
background image

1

Svensk f�rfattningssamling

F�rordning

om �ndring i f�rordningen (1999:58) om f�rbud mot vissa

h�lsofarliga varor

Utf�rdad den 4 oktober 2018

Regeringen f�reskriver1 att bilagan till f�rordningen (1999:58) om f�rbud
mot vissa h�lsofarliga varor ska ha f�ljande lydelse.

Denna f�rordning tr�der i kraft den 12 november 2018.

P� regeringens v�gnar

ANNIKA STRANDH�LL

Kjell Rempler
(Socialdepartementet)

1 Se Europaparlamentets och r�dets direktiv (EU) 2015/1535 av den 9 september 2015 om ett

informationsf�rfarande betr�ffande tekniska f�reskrifter och betr�ffande f�reskrifter f�r informa-

tionssamh�llets tj�nster.

SFS

2018:1587

Publicerad
den

9 oktober 2018

background image

2

SFS

Bilaga2

F�rteckning �ver varor som ska anses som h�lsofarliga varor enligt

lagen om f�rbud mot vissa h�lsofarliga varor

N-metyl-1-(3,4-metylendioxifenyl)-2-butylamin (MBDB)
1-(3,4-metylendioxifenyl)-2-butylamin (BDB)
5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT)
5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT)
5-metoxi-alfametyltryptamin (5-MeO-AMT)
2,5-dimetoxi-4-etylfenetylamin (2C-E)
alfa-metyltryptamin (AMT)
2,5-dimetoxi-4-klorfenetylamin (2C-C)
2,5-dimetoxi-4-metylfenetylamin (2C-D)
4-acetoxi-N,N-diisopropyltryptamin (4-AcO-DIPT)
4-hydroxi-N,N-diisopropyltryptamin (4-HO-DIPT)
gammabutyrolakton (GBL)
1,4-butandiol (1,4-BD)
4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT)
4-hydroxi-N,N-metylisopropyltryptamin (4-HO-MIPT)
4-acetoxi-N,N-dietyltryptamin (4-AcO-DET)
4-hydroxi-N,N-dietyltryptamin (4-HO-DET)
1-(3-trifluormetylfenyl)piperazin (TFMPP)
2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4)
[2,3-dihydro-5-metyl-3-(4-morfolinylmetyl)pyrrolo[1,2,3-de]-1,4-

bensoxazin-6-yl]-1-naftalenylmetanon (WIN 55,212-2)

5-(1,1-dimetylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclo-

hexyl]fenol (CP 55,940)

(2-metyl-1-pentylindol-3-yl)-(naftalen-1-yl)metanon (JWH-007)
(2-metyl-1-propyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-015)
(1-hexyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-019)
2-metylnaftalen-1-yl-(butylindol-3-yl)metanon (JWH-073 metylderivat)
4-metoxinaftalen-1-yl-(1-pentylindol-2-metyl-3-yl)metanon (JWH-098)
1-hexyl-2-fenyl-4-(1-naftoyl)pyrrol (JWH-147)
(4-metoxyfenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4)
4-metylhexan-2-amin (DMAA)
4-(2-aminopropyl)bensofuran (4-APB)
5-(2-aminopropyl)bensofuran (5-APB)
6-(2-aminopropyl)bensofuran (6-APB)
1-(1-bensofuran-5-yl)-N-metylpropan-2-amin (5-MAPB)
1-(5-fluoropentyl)-N-tricyklo[3.3.1.13,7]dek-1-yl-1H-indol-3-

karboxamid (STS-135)

1-pentyl-N-tricyklo[3.3.1.13,7]dek-1-yl-1H-indol-3-karboxamid (APICA

[JWH-018 adamantyl karboxamid])

1-pentyl-N-tricyklo[3.3.1.13,7]dek-1-yl-1H-indazol-3-karboxamid

(AKB48)

(1-pentyl-1H-indol-3-yl)tricyklo[3.3.1.13,7]dek-1-yl-metanon (AB-001)
1-[(5-kloropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (JWH-018

N-[5-kloropentyl] derivat)

2 Senaste lydelse 2018:539. �ndringen inneb�r bl.a. att (1-pentyl-1H-indol-3-yl)(2,2,3,3-

tetrametylcyclopropyl)metanon (UR-144), 1-(5-fluoropentyl)-1H-indol-3-karboxylsyra 8-

kinolinester

(5F-PB22),

N-[1-(aminokarbonyl)-2-metylpropyl]-1-(cyclohexylmetyl)-1H-

indazol-3-karboxamid (AB-CHMINACA), N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-pentyl-

1H-indazol-3-karboxamid (AB-PINACA),metyl-2-(1-(5-fluoropentyl)-1H-indazol-3-karbox-

amido)-3,3-dimetylbutanoat (5F-MDMB-PINACA) och N-[1-(2-fenyletyl)piperidin-4-yl]-N-

(2-fluorofenyl)propanamid (2-fluoro-fentanyl) tas bort ur f�rteckningen.

2018:1587

background image

3

SFS

N-[1-(aminokarbonyl)-2-metylpropyl]-1-[(4-fluorofenyl)metyl]-1H-

indazol-3-karboxamid (AB-FUBINACA)

N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-((4-fluorofenyl)metyl)-1H-

indazol-3-karboxamid (ADB-FUBINACA)

N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-

karboxamid (5F-AB-PINACA)

N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indol-3-

karboxamid (ADBICA)

kinolin-8-yl-1-pentyl-1H-indol-3-karboxylat (PB-22)
kinolin-8-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FUB-PB-22)
naftalen-1-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FDU-PB-22)
kinolin-8-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-PB-22

indazol)

kinolin-8-yl-1-(cyklohexylmetyl)-1H-indol-3-karboxylat (BB-22)
4-hydroxi-3,3,4-trimetyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on

(4-HTMPIPO)

(1-heptyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)metanon

(UR-144-heptylderivat)

N-bensyl-1-(5-fluoropentyl)-1H-indol-3-karboxamid (5F-SDB-006)
N-bensyl-1-pentyl-1H-indol-3-karboxamid (SDB-006)
N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-

karboxamid (ADB-PINACA)

N-(naftalen-1-yl)-1-pentyl-1H-indazol-3-karboxamid (MN-18)
1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indol-3-karboxamid (5F-NNEI)
N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-

karboxamid (5F-AB-144)

(1-(5-fluoropentyl)-1H-indazol-3-yl)(naftalen-1-yl)metanon (THJ-2201)
[1-(5-fluoropentyl)-1H-benso[d]imidazol-2-yl](naftalen-1-yl)metanon

(FUBIMINA)

metyl-2-(1-(5-fluoropentyl)-1H-indazol-3-karboxamido)-3-metylbuta-

noat (5F-AMB)

1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indazol-3-karboxamid

(5F-MN-18)

1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-pyrrolo[3,2-c]pyridin-3-karbox-

amid (5F-PCN)

naftalen-1-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-SDB-005)
N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-[(2-fluorofenyl)metyl]-1H-

indazol-3-karboxamid (AB-FUBINACA 2-fluorobensyl isomer)

N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-

indazol-3-karboxamid (ADB-CHMINACA)

7-kloro-N-[1-[((2-((cyklopropylsulfonyl)amino)-etyl)amino)karbonyl]-

2,2-dimetyl-propyl]-1-(4-fluorobensyl)-1H-indazol-3-karboxamid (ADSB-
FUB-187)

adamant-1-yl-(1-[(N-metylpiperidin-2-yl)metyl]-1H-indol-3-yl)metanon

(AM-1248)

N-(2-fenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-karboxamid

(CUMYL-5F-PICA)

1-(5-fluoropentyl)-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid

(CUMYL-5F-PINACA, SGT-25)

1-butyl-N-(2-fenylpropan-2-yl)-1H-indol-3-karboxamid (CUMYL-

BICA)

N-(2-fenylpropan-2-yl)-1-pentyl-1H-indol-3-karboxamid (CUMYL-

PICA)

2018:1587

background image

4

SFS

N-(2-fenylpropan-2-yl)-1-pentyl-1H-indazol-3-karboxamid (CUMYL-

PINACA)

N-(2-fenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)metyl)-1H-

indazol-3-karboxamid (CUMYL-THPINACA)

(1-(5-fluoropentyl)-1H-indazol-3-yl)(2,2,3,3-tetrametylcyklopropyl)meta-

non (FAB-144)

N-(adamant-1-yl)-1-(4-fluorobensyl)-1H-indazol-3-karboxamid (FUB-

AKB48)

metyl-2-(1-(4-fluorobensyl)-1H-indazol-3-karboxamido)-3-metyl-

butanoat (FUB-AMB)

metyl-2-([1-(5-fluoropentyl)-1H-indol-3-yl]karboxamido)-3-metyl-

butanoat (I-AMB)

(4-metylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)metanon (mepirapim)
naftalen-1-yl-1-(5-fluoropentyl)-1H-indol-3-karboxylat (NM-2201)
N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-

karboxamid (PX-1)

N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(5-fluoropentyl)-1H-indazol-

3-karboxamid (PX-2)

naftalen-1-yl-(1-pentyl-1H-indazol-3-yl)metanon (THJ-018)
1-(3,4-metylendioxifenyl)-2-(pyrrolidin-1-yl)butan-1-on (MDPBP)
2-(pyrrolidin-1-yl)-1-(tiofen-2-yl)butan-1-on (alfa-PBT)
2-(pyrrolidin-1-yl)-1-(tiofen-2-yl)pentan-1-on (alfa-PVT)
1-(4-metylfenyl)-2-(pyrrolidin-1-yl)hexan-1-on (MPHP)
1-(4-klorofenyl)-2-(pyrrolidin-1-yl)propan-1-on (4Cl-alfa-PPP)
1-fenyl-2-(pyrrolidin-1-yl)hexan-1-on (alfa-PHP)
1-fenyl-2-(pyrrolidin-1-yl)heptan-1-on (alfa-PEP)
1-(2,3-dihydro-1-bensofuran-5-yl)propan-2-amin (5-APDB)
1-(2,3-dihydro-1-bensofuran-6-yl)propan-2-amin (6-APDB)
1-(1-bensofuran-6-yl)-N-metylpropan-2-amin (6-MAPB)
2-(etylamino)-1-(4-metylfenyl)pentan-1-on (N-etyl-4-metylnorpente-

dron)

[1-[(tetrahydro-2H-pyran-4-yl)metyl]-1H-indol-3-yl](2,2,3,3-tetrametyl-

cyklopropyl)metanon (A-834735)

N-(adamantan-2-yl)-1-[(tetrahydro-2H-pyran-4-yl)metyl]-1H-indazol-3-

karboxamid (adamantyl-THPINACA)

N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-

indol-3-karboxamid (ADB-CHMICA)

N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(4-fluorobensyl)-1H-indazol-

3-karboxamid (APP-FUBINACA)

naftalen-1-yl-(9-pentyl-9H-karbazol-3-yl)metanon (EG-018)
(1-(4-fluorobensyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)meta-

non (FUB-144)

kinolin-8-yl-1-pentyl-1H-indazol-3-karboxylat (PB-22 indazol)
N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H-indazol-3-

karboxamid (AB-PINACA N-(2-fluoropentyl) isomer, 2F-AB-PINACA)

N-(1-amino-3-fenyl-1-oxopropan-2-yl)-1-(cyklohexylmetyl)-1H-

indazol-3-karboxamid (APP-CHMINACA)

N-(adamantyl)-1-(5-kloropentyl)-1H-indazol-3-karboxamid

(5C-AKB48)

metyl-2-(1-(4-fluorobensyl)-1H-indol-3-karboxamido)-3,3-dimetylbuta-

noat (MDMB-FUBICA)

metyl-2-(1-(4-fluorobensyl)-1H-indazol-3-karboxamido)-3,3-dimetyl-

butanoat (MDMB-FUBINACA)

naftalen-1-yl-1-pentyl-1H-indazol-3-karboxylat (SDB-005)

2018:1587

background image

5

SFS

N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-

indazol-3-karboxamid (5F-ADB-PINACA)

N-etyl-1,2-difenyletanamin (efenidin, NEDPA)
N-(1,2-difenyletyl)propan-2-amin (NPDPA)
N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-fluorofenyl)butanamid (4-fluoro-

butyrfentanyl, 4F-BF)

1-(4-klorofenyl)-2-(metylamino)propan-1-on (4-CMC, klefedron)
1-(3-klorofenyl)-2-(metylamino)propan-1-on (3-CMC, klofedron)
1-(4-bromofenyl)-2-(metylamino)propan-1-on (brefedron, 4-BMC)
2-amino-1-(4-bromo-2,5-dimetoxifenyl)etanon (bk-2C-B)
(1-(5-fluoropentyl)-1H-indazol-3-yl)(pyrrolidin-1-yl)metanon

(5F-PY-PINACA)

(1-(5-fluoropentyl)-1H-indol-3-yl)(pyrrolidin-1-yl)metanon

(5F-PY-PICA)

etyl-2-(1-[4-fluorobensyl]-1H-indazol-3-karboxamido)-3-metylbutanoat

(EMB-FUBINACA)

etyl-2-(1-[5-fluoropentyl]-1H-indazol-3-karboxamido)-3-metylbutanoat

(5F-EMB-PINACA)

metyl-2-(9-(cyklohexylmetyl)-9H-karbazol-3-karboxamido)-3,3-dime-

tylbutanoat (MDMB-CHMCZCA)

N,N-dietyl-6-metyl-1-propionyl-9,10-didehydroergolin-8-karboxamid

(1p-LSD)

2-[(metylamino)metyl]-3,4-dihydro-(2H)-naftalen-1-on (meftetramin,

MTTA)

1-(2,3-dihydrobensofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on

(5-DBFPV)

1-(3,4-dimetoxifenyl)-2-(pyrrolidin-1-yl)pentan-1-on (3,4-dimetoxi-alfa-

PVP)

1-(3,4-dimetoxifenyl)-2-(pyrrolidin-1-yl)hexan-1-on (3,4-dimetoxi-alfa-

PHP)

1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)heptan-1-on (4F-alfa-PEP)
1-fenyl-2-(pyrrolidin-1-yl)oktan-1-on (alfa-POP)
1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)propan-1-on (4-MeO-alfa-PPP)
2-(etylamino)-1-(2-metylfenyl)propan-1-on (2-MEC)
3-metoxi-2-(metylamino)-1-(4-metylfenyl)propan-1-on (mexedron,

4-MMC-OMe)

N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-metoxifenyl)butanamid

(4-metoxibutyrfentanyl, 4-MeO-BF)

1-(5-fluoropentyl)-N-fenyl-1H-indol-3-karboxamid (LTI-701)
(naftalen-1-yl)[4-(pentyloxi)naftalen-1-yl]metanon (CRA-13)
[9-(5-fluoropentyl)-9H-karbazol-3-yl](naftalen-1-yl)metanon (EG-2201)
metyl-2-(1-(cyklohexylmetyl)-1H-indol-3-karboxamido)-3-metyl-

butanoat (MMB-CHMICA, AMB-CHMICA)

etyl-2-(naftalen-2-yl)-2-(piperidin-2-yl)acetat (etylnaftidat, HDEP-28)
2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on

(TH-PVP)

1-(4-klorofenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4Cl-alfa-PVP)
1-(4-bromofenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4Br-alfa-PVP)
1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)pentan-1-on (4-MeO-alfa-PVP)
1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)butan-1-on (4F-alfa-PBP)
1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)butan-1-on (4-MeO-alfa-PBP)
1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)heptan-1-on (4-MeO-alfa-PEP)
1-(4-fluorofenyl)-2-(pyrrolidin-1-yl)hexan-1-on (4F-alfa-PHP)

2018:1587

background image

6

SFS

2-(metylamino)-1-(4-metylfenyl)butan-1-on (4-metylbufedron,

4-Me-MABP)

2-(metylamino)-1-(4-metylfenyl)pentan-1-on (4-metylpentedron)
1-fenyl-2-[(1-metyletyl)amino]pentan-1-on (N-isopropylnorpentedron,

NiPP)

1-(4-fluorofenyl)-2-[(1-metyletyl)amino]pentan-1-on (4F-N-isopropyl-

norpentedron)

1-(4-fluorofenyl)-2-(metylamino)pentan-1-on (4F-pentedron)
2-(etylamino)-1-fenylpentan-1-on (N-etylnorpentedron)
2-(etylamino)-1-fenylhexan-1-on (N-etylnorhexedron)
1-(1,3-bensodioxol-5-yl)-2-(etylamino)pentan-1-on (efylon)
2-(etylamino)-1-(4-klorofenyl)propan-1-on (4-kloroetkatinon, 4-CEC)
N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-klorofenyl)-2-metylpropanamid

(4-kloroisobutyrfentanyl, 4Cl-iBF)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]pentanamid (valerylfentanyl)
N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]cyklopentankarboxamid

(cyklopentylfentanyl)

1-(4-metoxifenyl)-2-(pyrrolidin-1-yl)oktan-1-on (4-MeO-alfa-POP)
1-(4-cyanobutyl)-N-(2-fenylpropan-2-yl)-1H-indazol-3-karboxamid

(CUMYL-4CN-BINACA)

2-(2-fluorofenyl)-2-(metylamino)cyklohexanon (2-fluorodeskloroketa-

min)

2-fenyl-2-(metylamino)cyklohexanon (deskloroketamin)
etyl-2-(4-fluorofenyl)-2-(piperidin-2-yl)acetat (4-fluoroetylfenidat,

4F-EPH)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-benso[d][1,3]dioxol-5-karbox-

amid (bensodioxolfentanyl)

N-[2-(dietylamino)cyklohexyl]-3,4-dikloro-N-metylbensamid (U-49900)
1-fenyl-4-metyl-2-(pyrrolidin-1-yl)pentan-1-on (alfa-PiHP)
1-fenyl-2-(1-metyletylamino)hexan-1-on (N-isopropylnorhexedron,

NiPH)

2-(etylamino)-1-(4-fluorofenyl)butan-1-on (4-fluoro-N-etylbufedron,

4F-NEB)

N-(2-fenylpropan-2-yl)-1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridin-3-

karboxamid (CUMYL-5F-P7AICA)

(1-metoxi-3,3-dimetyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-1H-

indazol-3-karboxylat (MO-AMB, MO-CHMINACA)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-3-fenylpropanamid (3-fenyl-

propanoylfentanyl)

N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]bensamid (bensoylfentanyl)
N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-2,2,3,3-tetrametylcyklo-

propan-1-karboxamid (tetrametylcyklopropanfentanyl)

2-(2,4-diklorofenyl)-N-[2-(dimetylamino)cyklohexyl]-N-metylacetamid

(U-48800)

4-acetoxi-N-etyl-N-metyltryptamin (4-AcO-MET)
1-(4-fluorofenyl)-4-metyl-2-(pyrrolidin-1-yl)pentan-1-on (4F-alfa-PiHP)
2-(etylamino)-1-(4-fluorofenyl)pentan-1-on (4-fluoro-N-etylpentedron,

4F-NEP)

1-(1-bensofuran-6-yl)-N-etylpropan-2-amin (6-EAPB)
N-(1-bensylpiperidin-4-yl)-N-fenylacetamid (acetylbensylfentanyl)
N-(1-bensylpiperidin-4-yl)-N-fenylbensamid (bensoylbensylfentanyl)
N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-kloropentyl)-1H-indazol-3-

karboxamid (5Cl-AB-PINACA)

2018:1587

background image

7

SFS

1-(4-cyanobutyl)-N-(2-fenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-

karboxamid (CUMYL-4CN-B7AICA)

4-hydroxi-N,N-dipropyltryptamin (4-HO-DPT)
N-etyl-N-metyltryptamin (MET)
3-[1-(etylamino)cyklohexyl]fenol (3-hydroxieticyklidin, 3-HO-PCE)
N-etyl-1-(4-fluorofenyl)propan-2-amin (4-fluoroetamfetamin, 4-FEA)
2-(etylamino)-1-fenyl-4-metylpentan-1-on (NEiH)
1-(3-fluorofenyl)-2-(pyrrolidin-1-yl)pentan-1-on (3F-alfa-PVP)
N-[1-(2-fenyletyl)piperidin-4-yl]-N-(4-hydroxifenyl)butanamid

(4-hydroxibutyrfentanyl)

N-[2-(dimetylamino)cyklohexyl]-N-isopropyl-3,4-diklorobensamid

(isopropyl-U-47700)

4-(2-fluorofenyl)-2-kloro-9-metyl-6H-tieno[3,2-f][1,2,4]triazolo[4,3-a]

[1,4]diazepin (fluklotizolam)

2-(dimetylamino)-1-(4-klorofenyl)propan-1-on (4-klorodimetylkatinon,

4-CDMC, 4-CDC)

2-(dimetylamino)-1-(4-metylfenyl)propan-1-on (4-metyl-N,N-dimetyl-

katinon, 4-MDMC)

1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)butan-1-on (5-PPDi)
N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(cyklohexylmetyl)-3-(4-fluoro-

fenyl)-1H-pyrazol-5-karboxamid (3,5-AB-CHMFUPPYCA)

metyl-3,3-dimetyl-2-[1-(pent-4-en-1-yl)-1H-indazol-3-karboxamido]-

butanoat (MDMB-4en-PINACA)

metyl-3-metyl-2-[1-(pent-4-en-1-yl)-1H-indol-3-karboxamido]butanoat

(MMB-022, AMB-4en-PICA)

metyl-3-fenyl-2-[1-(5-fluoropentyl)-1H-indol-3-karboxamido]propanoat

(MPhP-2201)

N-[2-(dimetylamino)cyklohexyl]-N-metyl-2H-1,3-bensodioxol-

5-karboxamid (3,4-metylendioxi-U-47700)

salvinorin A
alla delar av v�xten Salvia divinorum fr�n vilka salvinorin A inte blivit

extraherat och oavsett under vilka ben�mningar de f�rekommer


Salter av �mnena n�r s�dana kan f�rekomma.

2018:1587

;